New drug LH-001 put to the test in healthy volunteers
NCT ID NCT06546449
First seen Apr 23, 2026 · Last updated May 02, 2026 · Updated 1 time
Summary
This early-stage study is testing the safety of a new drug called LH-001 in 56 healthy adults aged 18 to 60. Participants will receive either the drug or a placebo, and researchers will monitor for side effects and how the drug moves through the body. The study is currently on hold.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Ohio State University
Columbus, Ohio, 43221, United States
Conditions
Explore the condition pages connected to this study.